Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia

References

• Al-Kaabba AF, Al-Hamdan NA, El Tahir A, Abdalla AM, Saeed AA, Hamza MA. Prevalence and correlates of dyslipidemia among adults in Saudi Arabia: results from a national survey. Open J Endocr Metab Dis. 2012;2:89. doi:10.4236/ojemd.2012.24014
   Google Scholar
• Al-Nozha MM, Arafah MR, Al-Maatouq MA, et al. Hyperlipidemia in Saudi Arabia. Saudi Medi J. 2008;29:282–287.
   PubMed Web of Science ®Google Scholar
• Ogbeide DO, Karim A, Al-Khalifa IM, Siddique S. Population based study of serum lipid levels in Al-Kharj Health Center, Saudi Arabia. Saudi Med J. 2004;25:1855–1857.15711654
   PubMed Web of Science ®Google Scholar
• World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. World Health Organization; 2002.
   Google Scholar
• Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults E. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486–2497. doi:10.1001/jama.285.19.248611368702
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2017 abridged for primary care providers. Clin Diabetes. 2017;35:5. doi:10.2337/cd16-006728144042
   PubMedGoogle Scholar
• Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375–2414. doi:10.1093/eurheartj/ehm31617726041
   PubMed Web of Science ®Google Scholar
• Briel M, Studer M, Glass TR, Bucher HC. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2004;117:596–606. doi:10.1016/j.amjmed.2004.04.02215465509
   PubMed Web of Science ®Google Scholar
• Thavendiranathan P, Bagai A, Brookhart MA, Choudhry NK. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166:2307–2313. doi:10.1001/archinte.166.21.230717130382
   PubMed Web of Science ®Google Scholar
• McPherson R, Frohlich J, Fodor G, Genest J. Canadian Cardiovascular Society position statement–recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol. 2006;22:913–927. doi:10.1016/S0828-282X(06)70310-516971976
   PubMed Web of Science ®Google Scholar
• Parris ES, Lawrence DB, Mohn LA, Long L. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care. 2005;28:595–599. doi:10.2337/diacare.28.3.59515735194
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497. doi:10.1056/NEJMra05010016079372
   PubMed Web of Science ®Google Scholar
• Maningat P, Gordon BR, Breslow JL. How do we improve patient compliance and adherence to long-term statin therapy? Curr Atheroscler Rep. 2013;15:291. doi:10.1007/s11883-012-0291-723225173
   PubMed Web of Science ®Google Scholar
• Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462–467. doi:10.1001/jama.288.4.46212132976
   PubMed Web of Science ®Google Scholar
• Farsaei S, Sabzghabaee AM, Amini M, Zargarzadeh AH. Adherence to statin therapy in patients with type 2 diabetes: an important dilemma. J Res Med Sci. 2015;20:109.25983760
   PubMed Web of Science ®Google Scholar
• Wawruch M, Zatko D, Wimmer G Jr, et al. Patient‐related characteristics associated with non‐persistence with statin therapy in elderly patients following an ischemic stroke. Pharmacoepidemiol Drug Saf. 2017;26:201–207. doi:10.1002/pds.v26.227935151
   PubMed Web of Science ®Google Scholar
• Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455–461. doi:10.1001/jama.288.4.45512132975
   PubMed Web of Science ®Google Scholar
• Juarez DT, Tan C, Davis J, Mau M. Factors affecting sustained medication adherence and its impact on healthcare utilization in patients with diabetes. J Pharm Health Serv Res. 2013;4:89–94. doi:10.1111/jphs.2013.4.issue-223717343
   PubMedGoogle Scholar
• Pittman DG, Chen W, Bowlin SJ, Foody JM. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol. 2011;107:1662–1666. doi:10.1016/j.amjcard.2011.01.05221439533
   PubMed Web of Science ®Google Scholar
• Bates T, Connaughton V, Watts G. Non-adherence to statin therapy: a major challenge for preventive cardiology. Expert Opin Pharmacother. 2009;10:2973–2985. doi:10.1517/1465656090337618619954271
   PubMed Web of Science ®Google Scholar
• Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005–2016.12814710
   PubMed Web of Science ®Google Scholar
• Program TRotNCE. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143–3421. doi:10.1161/circ.106.25.314312485966
   PubMed Web of Science ®Google Scholar
• Fedder DO, Koro CE, Gilbert J. New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population. Circulation. 2002;105:152–156. doi:10.1161/hc0202.10197111790693
   PubMed Web of Science ®Google Scholar
• Schultz JS, O’Donnell JC, McDonough KL, Sasane R, Meyer J. Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population. Am J Manag Care. 2005;11:306–312.15898219
   PubMed Web of Science ®Google Scholar
• Burton WN, Chen C-Y, Schultz AB, Edington DW. The association between achieving low-density lipoprotein cholesterol (LDL-C) goal and statin treatment in an employee population. Popul Health Manag. 2010;13:1–8. doi:10.1089/pop.2009.002020158317
   PubMed Web of Science ®Google Scholar
• Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51:S11. doi:10.1097/MLR.0b013e31829b1d2a23774515
   PubMed Web of Science ®Google Scholar
• Slabaugh SL, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting. Drugs Aging. 2010;27:1019–1028. doi:10.2165/11584990-000000000-0000021087071
   PubMed Web of Science ®Google Scholar
• Grimmsmann T, Himmel W. Polypharmacy in primary care practices: an analysis using a large health insurance database. Pharmacoepidemiol Drug Saf. 2009;18:1206–1213. doi:10.1002/pds.v18:1219795368
   PubMed Web of Science ®Google Scholar
• Monégat M, Sermet C, Perronnin M, Rococo E. Polypharmacy: definitions, measurement and stakes involved: review of the literature and measurement tests. Quest D’économie La Santé. 2014;204:1–8.
   Google Scholar
• Warren JR, Falster MO, Fox D, Jorm LJP. Factors influencing adherence in long‐term use of statins. Pharmacoepidemiol Drug Saf. 2013;22:1298–1307. doi:10.1002/pds.352624105731
   PubMed Web of Science ®Google Scholar
• Yudin ZM, Yaacob LH, Hassan NB, Ismail SB, Draman N, Yusoff SSM. Achievement of LDL cholesterol goal and adherence to statin by diabetes patients in Kelantan. Malays J Med Sci. 2017;24:44. doi:10.21315/mjms2017.24.1.12
   Google Scholar
• Svensson E, Nielsen RB, Hasvold P, Aarskog P, Thomsen R. Statin prescription patterns, adherence, and attainment of cholesterol treatment goals in routine clinical care: a Danish population-based study. Clin Epidemiol. 2015;7:213. doi:10.2147/CLEP.S7814525759601
   PubMed Web of Science ®Google Scholar
• Donnelly L, Doney A, Morris A, Palmer C, Donnan P. Long‐term adherence to statin treatment in diabetes. Diabet Med. 2008;25:850–855. doi:10.1111/dme.2008.25.issue-718644071
   PubMed Web of Science ®Google Scholar
• Alwhaibi M, Balkhi B, Alhawassi TM, et al. Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia. BMJ Open. 2018;8:e020852. doi:10.1136/bmjopen-2017-020852
   Web of Science ®Google Scholar
• Dobrică EC, Găman MA, Cozma MA, Bratu OG, Pantea Stoian A, Diaconu CC. Polypharmacy in type 2 diabetes mellitus: insights from an internal medicine department. Medicina (Kaunas). 2019;55:436. doi:10.3390/medicina55080436
   Web of Science ®Google Scholar
• Gaman M, Dobrica E, Pascu E, et al. Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: focus on hypertension, metabolic syndrome and obesity. J Mind Med Sci. 2019;6:157–161. doi:10.22543/7674.61.P157161
   Web of Science ®Google Scholar
• Labib AM, Martins AP, Raposo JF, Torre C. The association between polypharmacy and adverse health consequences in elderly type 2 diabetes mellitus patients; a systematic review and meta-analysis. Diabetes Res Clin Pract. 2019;155:107804.31376400
   PubMed Web of Science ®Google Scholar
• Skalicky J, Muzakova V, Kandar R, Meloun M, Rousar T, Palicka V. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med. 2008;46:499–505. doi:10.1515/CCLM.2008.09618298345
   PubMed Web of Science ®Google Scholar
• Lahera V, Goicoechea M, Garcia de Vinuesa S, et al. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr Med Chem. 2007;14:243–248. doi:10.2174/09298670777931338117266583
   PubMed Web of Science ®Google Scholar
• Sørensen AL, Hasselbalch HC, Nielsen CH, Poulsen HE, Ellervik C. Statin treatment, oxidative stress and inflammation in a Danish population. Redox Biol. 2019;21:101088.30594900
   PubMed Web of Science ®Google Scholar